The Alere INRatio recall was issued by the FDA because the blood clot monitoring systems were shown to deliver incorrect test results. This is a Class 1 recall, the most serious classification issued by the FDA for medical device product failures because inaccurate INR test levels could result in serious injury or death.
The recall affects Alere’s INRatio and INRatio2 PT/INR Monitoring Systems including:
* See below for a complete list of recalled devices
The Alere patient INR tests measure blood coagulation activity. If the blood clot factor (INR level), is too low, a patient could suffer excess bleeding. If it is too high there is a risk of blood clot formation (thrombosis) that could block the circulatory system. The recalled test kits are known to have delivered inaccurate results putting patients at risk for serious injury or death including, among other conditions, subdural hematoma, hemorrhagic stroke, uncontrollable bleeding, organ damage, or a related injury.
If you or someone in your family has used one or more of the devices affected by the Alere INRatio recall to test and control anticoagulation (blood clot) therapy you should consult your doctor immediately. It is important that you request a new blood test for anticoagulation clotting factors to make sure your results are normal. You should also seek out legal counsel to protect your interests in the event you have, or may suffer an injury from use of the recalled Alere test kits or monitors.
Stark & Stark attorneys are actively seeking and filing legal claims for those injured or killed from use of recalled Alere INRatio test kits, and INRatio2 PT/INR Monitoring Systems. Please contact your doctor first to get retested, and then contact Stark & Stark for assistance.
Background
Alere INRatio test strips and monitors measure a patient’s International Normalized Ratio (INR) which is the blood factor that shows how quickly your blood clots. The devices are generally prescribed for patients taking Coumadin (warfarin) or other blood thinning medications. The tests are necessary to maintain normal blood clotting activity in affected patients. Depending on the test results, medication dosage is changed to normalize the results. The thinner your blood, the longer it takes to clot, the higher your INR value. The thicker your blood, the faster it clots, the lower your INR value. High INR can lead to uncontrollable bleeding, while low INR can lead to a risk of blood clot or stroke.
Device Failures
Under certain conditions, the Alere INRatio and INRatio2 PT/INR Monitoring Systems were found to generate inaccurately low INR readings. Simply stated, the systems were inaccurately reading INR levels in patients, which resulted in dangerously inaccurate dosage changes, which put patients at a high risk for potentially deadly bleeding events. Essentially the revised or continued medication dosage was thinning already thin blood to dangerous levels.
Based on thousands of patient complaints of injuries (including cranial bleeding, stroke and death), all of the following Alere INRatio and INRatio2 PT/INR Monitoring System monitors and test strips manufactured and distributed from April 1, 2008 to July 8, 2016, were recalled:
You may have a claim if you or someone in your family used one or more of these devices during the recall years of 2008-2016 and suffered an unexpected injury or deadly bleeding event.
Stark & Stark attorneys are actively negotiating Alere INRatio and INRatio2 PT/INR Monitoring System settlements and evaluating claims for Alere INRatio and INRatio2 PT/INR Monitoring System lawsuits on behalf of patients injured or killed from use of the potentially defective devices. We are committed to holding drug and medical device manufacturers liable when their products improperly endanger the public and put patients at a high risk of injury or death.
Our Alere INRatio and INRatio2 PT/INR Monitoring System lawyers are experienced in medical device and pharmaceutical product failure negotiating strategies that get the best results for our clients.
If you or someone in your family has been affected by the INRatio recall, you should contact us to assess your eligibility for a claim against the manufacturers of the Alere INRatio test kits and monitors and to help you understand the Alere INRatio and INRatio2 PT/INR Monitoring System lawsuit and potential settlement process.
Stark & Stark Attorneys Recognized as New Jersey “Super Lawyers” and “Rising Stars” in 2026
Stark & Stark is pleased to announce that 15 of its attorneys have been selected for inclusion in the list of 2026 New Jersey Super Lawyers,...Bruce Stern, Esq. Secures $1,000,000 Settlement in Motor Vehicle Collision Case
Bruce Stern, Esq. recently secured a $1,000,000 settlement in a motor vehicle collision case.* “This case highlights how quickly things can go...Deborah Dunn, Esq. Elected to Board of Directors for Angel Flight East
Stark & Stark is pleased to announce that Deborah Dunn, Esq., Shareholder and Civil Trial Attorney, has been elected to the Board of Directors...Michael Jordan, Esq. Joins the Board of the Lawrence Township Community Foundation
It is our pleasure to announce that Michael Jordan, Esq. has joined the board of the Lawrence Township Community Foundation, an organization...Joseph Lemkin, Esq. Named to ROI-NJ Influencers: Power List 2026 – Law
Stark & Stark is proud to share that Joseph Lemkin, Esq., Shareholder, has been named to the 2026 Influencers: Power List in the Law category...Joseph Cullen, Esq. and Nicole Durso, Esq. Secure $2,000,000 Settlement in Personal Injury Matter
Joseph Cullen, Esq. and Nicole Durso, Esq. recently secured a $2,000,000 settlement in a personal injury matter involving a pedestrian who was struck...James Creegan, Esq. Appointed to Board of The 200 Club of Mercer County
It is our pleasure to announce that James Creegan, Esq. has been appointed to the Board of Directors of The 200 Club of Mercer County, an...